|
Market Closed -
Euronext Paris
11:55:00 2026-11-19 am EST
|
5-day change | 1st Jan Change | ||
| 19.10 EUR | 0.00% |
|
+0.26% | -36.96% |
| Sep. 17 | Boiron SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Apr. 22 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 332M 364M 307M 277M 521M 33.98B 542M 3.7B 1.46B 18.34B 1.36B 1.34B 57.91B | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 284M 311M 262M 237M 446M 29.08B 464M 3.17B 1.25B 15.69B 1.17B 1.14B 49.56B | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
12.84% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| BOI | Real-time | |
| BOIp | Real-time | ||
| BON | Delayed | ||
| 0DTF | Real-time | ||
| BON | Delayed | ||
| BON | Real-time |
| 1 week | +0.26% | ||
| Current month | +2.14% | ||
| 1 month | +5.23% | ||
| 3 months | -27.10% | ||
| 6 months | -28.73% | ||
| Current year | -36.96% |
| 1 week | 18.85 | 19.25 | |
| 1 month | 17.45 | 20.3 | |
| Current year | 16.9 | 30.95 | |
| 1 year | 16.9 | 32.25 | |
| 3 years | 16.9 | 42.8 | |
| 5 years | 16.9 | 56.5 | |
| 10 years | 16.9 | 92.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 2024-12-31 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 2021-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 2011-06-30 |
| Director/Board Member | 54 | 2010-03-09 | |
| Director/Board Member | 51 | 2013-05-22 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/29/23 | Sell | Director | 198,664 | 1.1323% | ||
| 10/29/23 | Sell | Director | 462,964 | 2.6387% | ||
| 10/29/23 | Sell | Director | 4,748 | 0.0271% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| 0.00% | +0.26% | -28.86% | -52.06% | 364M | ||
| -1.54% | -5.40% | +28.64% | +125.94% | 1,232B | ||
| -2.16% | -6.61% | +30.75% | +76.62% | 656B | ||
| -1.28% | -4.64% | +20.55% | +103.01% | 506B | ||
| -0.84% | -1.60% | +28.95% | +68.67% | 382B | ||
| -2.51% | -9.02% | +40.66% | +30.21% | 340B | ||
| -3.01% | -4.99% | +24.75% | +51.31% | 294B | ||
| -2.54% | -4.68% | -2.34% | +31.38% | 278B | ||
| -0.35% | -6.19% | +27.97% | +65.12% | 240B | ||
| -0.67% | -1.08% | +29.72% | +118.59% | 210B | ||
| Average | -1.55% | -2.15% | +20.08% | +61.88% | 414B | |
| Weighted average by Cap. | -1.75% | -2.67% | +26.65% | +86.59% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 488M 535M 451M 407M 766M 49.96B 796M 5.44B 2.15B 26.96B 2.01B 1.96B 85.15B | 501M 549M 463M 418M 787M 51.34B 819M 5.6B 2.21B 27.71B 2.06B 2.02B 87.51B |
| Net income | 11.34M 12.43M 10.48M 9.46M 17.81M 1.16B 18.52M 127M 50.04M 627M 46.63M 45.65M 1.98B | 32.64M 35.79M 30.18M 27.24M 51.3M 3.34B 53.32M 365M 144M 1.81B 134M 131M 5.7B |
| Net Debt | -49.74M -54.54M -45.99M -41.5M -78.16M -5.1B -81.24M -555M -220M -2.75B -205M -200M -8.69B | -47.86M -52.47M -44.25M -39.93M -75.2M -4.9B -78.17M -534M -211M -2.65B -197M -193M -8.36B |
Employees
2,623
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-19 | €19.10 | 0.00% | 258 |
| 26-11-18 | €19.10 | -0.78% | 649 |
| 26-11-17 | €19.25 | +1.32% | 1,291 |
| 26-11-16 | €19.00 | -1.04% | 1,591 |
| 26-11-13 | €19.20 | +0.79% | 1,710 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
Select your edition
All financial news and data tailored to specific country editions
















